Insider Stock Trades: Immunic Among Notable Acquisitions Insider Stock Trades: Immunic Among Notable Acquisitions

Written By Michael Gary Scott

The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

Insider Trading Spotlight: OPKO Health

  • The Deal: OPKO Health, Inc. OPK 10% owner Frost Gamma Investments Trust acquired a total of 500,000 shares an average price of $0.99. The purchase totaled around $496,150.
  • Latest Development: On Feb. 27, OPKO Health posted positive quarterly results.
  • Industry Focus: OPKO Health Inc is a diversified biotechnology company involved in pharmaceutical and diagnostic development programs.

Immunic: A Closer Look

  • The Acquisition: Immunic, Inc. IMUX President and CEO Daniel Vitt acquired a total of 14,000 shares at an average price of $1.31. The investment amounted to approximately $18,333.
  • Recent Event: On Feb. 22, Immunic reported better-than-expected fourth-quarter results.
  • Company Snapshot: Immunic Inc is a clinical-stage biopharmaceutical company focusing on developing oral immunology therapies for chronic inflammatory and autoimmune conditions such as ulcerative colitis and psoriasis.

Check This Out: HP, Best Buy And 3 Stocks To Watch Heading Into Thursday

Exploring New Ventures: Fresh Tracks Therapeutics

  • The Investment: Fresh Tracks Therapeutics, Inc. FRTX 10% owner Exploration Capital, LLC acquired a total of 20,109 shares at an average price of $0.90. An expenditure of about $18,098 was made on these shares.
  • Recent Performance: The company’s stock experienced a 6% decline over the past month.
  • Corporate Focus: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical business dedicated to improving patient outcomes with innovative prescription therapeutics.
See also  Amazon Earnings Loom: Are Shares a Buy?